Research & Development



  “換一個法子,把刀子換成木頭的。”   “大夫如果把雲瑯看做一個蠶農,要眼睜睜的看著自己辛苦養蠶,繅絲,然後被黃氏這樣的家族盤剝,就很理解雲某為何會如此不留情面的對付黃氏了。”撸一撸   甦稚站在地道口一邊咬著一只果子,一邊鄙夷的道︰“師姐有身孕,你們要想胡來,挑一個柔軟,暖和的地方!”撸啊撸   母狼成為狼王很罕見,她身上雪白的皮毛,如今變成了骯髒的土黃色,而且毛色不均勻,有一塊沒一塊的,孤獨的在山林里巡梭。   “我當時尿褲子了。”很很撸在线视频   該罵的時候罵,該打的時候騎在孟氏兄弟的身上毆打他們,在他們得病,或者餓肚子的時候照顧他們……

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo